Poster Presentations Session I
Poster Presentations Session I Saturday, 16 September 2017
POSTERS SET-UP: 8:15 - 8:30
POSTERS DISPLAY HOURS: 8:30 - 20:00
POSTER AUTHOR DISCUSSION: 18:30 - 19:30
POSTERS DISMANTLE: 20:00


Poster display locations are shown below the poster codes
GASTROINTESTINAL DISORDERS - Clinical Outcomes Studies
PGI1
H5
SYSTEMATIC REVIEW OF OBSERVATIONAL STUDIES OF INTERFERON-FREE TREATMENTS FOR CHRONIC HEPATITIS C
Ferreira VL, Leonart L, Tonin FS, Pontarolo R
Universidade Federal do Paraná, Curitiba, Brazil

PGI2
H6
BOCEPREVIR AND TELAPREVIR EFFECTIVENESS AND SAFETY IN A BRAZILIAN COHORT OF CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS: A MULTICENTRIC LONGITUDINAL STUDY
Borba HH1, Wiens A1, Steimbach LM1, Tonin FS1, Pedroso ML2, Minowa E3, Piedade A4, Clark O4, Fernandez-Llimos F5, Pontarolo R1
1Universidade Federal do Paraná, Curitiba, Brazil, 2Gastroenterology Service, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil, 3Universidade de São Paulo, São Paulo, Brazil, 4Evidências-A Kantar Health Company, Rio de Janeiro, Brazil, 5University of Lisboa, Lisboa, Portugal

PGI3
H7
PREVALENCE AND ANTIMICROBIAL SENSITIVITY OF SALMONELLA FROM FECAL AND MILK SAMPLES OF LACTATING COWS, DEBRE-ZEIT, ETHIOPIA
Yizengaw HA
Dilla University, Dilla, Ethiopia

PGI4
H8
GENOTYPE AND LIVER FIBROSIS DISTRIBUTION AMONG HEPATITIS C PATIENTS IN A SINGLE CENTER IN THE SOUTH OF BRASIL: A CROSS-SECTIONAL STUDY
Borba HH1, Wiens A1, Ivantes CA2, Santos JC2, Tawil FB2, Pontarolo R1
1Universidade Federal do Paraná, Curitiba, Brazil, 2Centro de Orientação e Aconselhamento - COA, Curitiba, Brazil

PGI5
H9
WAITING LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS
Silva G1, Andrade VG1, Paixão VN1, Pardini MI1, Grotto R1, Bráz AM1, Golim M1, Yamashiro FS1, Oliveira CV1, Lastoria L1, Moreira A1, Fernandes AS2
1UNESP, Botucatu, Brazil, 2MSD, São Paulo, Brazil

GASTROINTESTINAL DISORDERS - Cost Studies
PGI6
H10
HOW DOES HIGH MELD SCORE INCREASES TOTAL EXPENDITURE ON HEALTH SYSTEM? A MICRO-COSTING PROSPECTIVE COHORT STUDY.
Turri JA1, Ferreira LA2, Decimoni TC3, Campolina AG4
1Sao Paulo Medical School - Sao Paulo University, Sao Paulo, Brazil, 2University of Sao Paulo, Sao Paulo, Brazil, 3Sao Paulo Medical School, Sao Paulo, SK, Brazil, 4Cancer Institute of the State of Sao Paulo, Sao Paulo, Brazil

PGI7
H11
COSTO DE LA ATENCIÓN DE LA ENFERMEDAD DE CROHN EN UN CENTRO ASISTENCIAL DE BOGOTÁ, COLOMBIA
Molano B1, Bryón A2, Jaimes D3
1fundacion santafe de bogota, Bogota, Colombia, 2HEORT - Health Economics & Outcomes Research Team, Bogota, Colombia, 3HEORT, Bogota, Colombia

PGI8
H12
CUSTO EFETIVIDADE DO USO DOS INIBIDORES DE PROTEASE NO TRATAMENTO DA HEPATITE C CRÔNICA: COMPARAÇÃO ENTRE O USO UNIVERSAL E O USO RESTRITO NA FIBROSE AVANÇADA.
Rodrigues MP1, Mosegui GB2, Vianna CM3, Oliveira FS1, da Cunha GN3, Jardim FN3, Valle PM3
1UERJ, Rio de Janeiro,, Rio de Janeiro, Brazil, 2Universidade Federal Fluminense, Niterói, Brazil, 3Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

PGI9
H13
EFFECTIVENESS AND COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR AND BOCEPREVIR FOR CHRONIC HEPATITIS C: A DECISION ANALYSIS FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
Borba HH1, Rochau U2, Wiens A1, Sroczynski G3, Siebert U4, Pontarolo R1
1Universidade Federal do Paraná, Curitiba, Brazil, 2UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making & HTA, Dept. of Public Health, Health Services Research and HTA, Hall i.T., Austria, 3UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, Hall i.T., Austria, 4Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria

GASTROINTESTINAL DISORDERS - Patient-Reported Outcomes & Patient Preference Studies
PGI10
H14
A CONCEPTUAL MODEL FOR PEDIATRIC GASTROESOPHAGEAL REFLUX
Smith AB1, Hodgkinson V1, Okhuoya P1, Tatlock S2, Spencer H3, Arbuckle R3
1RB, Hull, UK, 2Adelphi Values Ltd, Bollington, UK, 3Adelphi Values Ltd, Bollington, Cheshire, UK

GASTROINTESTINAL DISORDERS - Health Care Use & Policy Studies
PGI11
WITHDRAWN

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.